We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Staphylococcal Pathogens Assessed in Periprosthetic Joint Infections

By LabMedica International staff writers
Posted on 04 Nov 2016
Print article
Periprosthetic joint infections (PJI) are the main complication of knee and hip prosthetic arthroplasty and between 1% and 3% of patients undergoing prosthesis implantation are affected by these infections.

The characteristics of periprosthetic joint infection (PJI) due to Staphylococcus lugdunensis have been assessed and compared to the characteristics of PJI due to Staphylococcus aureus and Staphylococcus epidermidis. S. lugdunensis is a coagulase-negative staphylococci (CoNS) that is considered part of the normal flora of human skin, as are other CoNS species.

Medical microbiologists at the Hôpital J. Ducuing (Toulouse, France) conducted a retrospective and descriptive study from 2000 to 2014, including patients from three orthopedic centers in the same area. Eighty-eight consecutive cases of monomicrobial staphylococcal PJI were analyzed; 28 due to S. lugdunensis, 30 to S. aureus, and 30 S. epidermidis. The diagnosis of PJI was established in the presence of one major criterion or two minor criteria: the major criteria were at least two positive periprosthetic cultures with phenotypically identical organisms, or a sinus tract communicating with the joint; minor criteria were a C-reactive protein (CRP) value greater than 10 mg/L and a histological analysis of periprosthetic tissue confirming a septic process.

For each suspected site, hard and soft tissue specimens were collected in sterile glass vials and articular fluid was inoculated into blood culture bottles. After inoculation into culture media, these were observed daily for microbial growth. Bacteriological criteria for a positive diagnosis of infection were the following: at least one positive sample for S. aureus-positive cultures; at least two positive samples for S. epidermidis- and S. lugdunensis-positive cultures. In the case of a positive culture, identification was performed by the Vitek 2 automated technique or the API Staph manual technique.

Clinical symptoms were more often reported in the S. lugdunensis group, and the median delay between surgery and infection was shorter for the S. lugdunensis group than for the S. aureus and S. epidermidis groups. As regards antibiotic susceptibility, the S. lugdunensis strains were susceptible to antibiotics and 61% of the patients could be treated with levofloxacin + rifampicin. The outcome of the PJI was favorable for 89% of patients with S. lugdunensis, 83% with S. aureus, and 97% with S. epidermidis. Nine unfavorable outcomes were reported in the total population.

The authors concluded that S. lugdunensis is classified as a CoNS, but the clinical features of S. lugdunensis PJI, the early aspect of the infection, and the relapses observed are similar to those in S. aureus PJI. Regarding the microbiological diagnosis, the species of CoNS in PJI must be identified precisely and treatment adapted to the antibiotic susceptibility, even if only one deep sample is positive in culture. The study was published in the October 2016 issue of the International Journal of Infectious Diseases.

Related Links:
Hôpital J. Ducuing


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.